Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 15/20 | 0.69 |
| ▸ | RARG | P13631 | 14/20 | 0.69 |
| ▸ | RARA | P10276 | 14/20 | 0.69 |
| ▸ | CYP26A1 | O43174 | 4/20 | 0.55 |
| ▸ | CYP26B1 | Q9NR63 | 4/20 | 0.55 |
| ▸ | RXRA | P19793 | 3/20 | 0.54 |
| ▸ | RXRB | P28702 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7154631 | 0.85 | RXRA (0.70) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL2331952 | 0.83 | RARB (1.00) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL8736104 | 0.81 | RXRA (0.50) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL9374463 | 0.79 | RARA (0.90) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL10541551 | 0.78 | RARB (0.79) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL6372648 | 0.77 | RARB (1.00) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL5712092 | 0.76 | RARB (0.79) | RARBRARGRARACYP26A1CYP26B1 | |
| Temarotene SCHEMBL8435859 | 0.75 | RARB (0.72) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL8950182 | 0.74 | RARB (0.79) | RARBRARGRARACYP26A1CYP26B1 | |
| SCHEMBL6148372 | 0.74 | CYP26A1 (0.58) | RARBRARGRARACYP26A1CYP26B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992015290-A1 | METHODS FOR TREATMENT OF SCARRING FIBROTIC ALOPECIA | KLIGMAN ALBERT M (US) | 1992-09-17 | — | — | WO | disclosed |